Azoury R, Goldwasser B, Wax Y, Perlberg S, Garti N, Sarig S
Urol Res. 1985;13(4):199-205. doi: 10.1007/BF00261824.
Ultrafiltration membranes of 10,000 d, 1,000 d and 500 d were used to remove urinary macromolecules from the urine of normal subjects and from the urine of stone forming patients. The filtrated urines were examined for their residual inhibitory potential for calcium-oxalate precipitation, by the discrimination method of Sarig et al. (D.I. test). The results of testing the filtrate were complementary to the information gained by analyses of retentates obtained in successive ultrafiltration. The method has an inherent advantage because the manipulation of solids retained on membranes may inadvertantly modify their inhibitory potential. At least two distinct groups of inhibitors were found in 20 normal urines. The first group has MW above 10,000 d while the second group of inhibitors has MW in the range of 500-1,000 d. The mean of the D.I. values increased dramatically from the normal range (less than 0.6) to the stone former range (greater than 1.1) (p less than 0.001) after the 500 d filtration. Some of the normal urines, even after the 500 d filtration, still had a degree of inhibitory potential. This inhibitory potential may be related to the inorganic compounds which were found in the urines. The inhibitory activity of macromolecules with MW above 10,000 d and below 500 delta was negligible in 7 stone formers (SF) urines. The relative contribution of 500-1,000 d macromolecules is the highest both in SF and normal urines.
使用截留分子量为10,000道尔顿、1,000道尔顿和500道尔顿的超滤膜,从正常受试者尿液和结石形成患者尿液中去除尿大分子物质。通过Sarig等人的鉴别方法(D.I.试验),检测过滤后的尿液对草酸钙沉淀的残留抑制潜力。滤液检测结果与连续超滤截留物分析所得信息互补。该方法具有内在优势,因为对膜上保留的固体进行操作可能会无意中改变其抑制潜力。在20份正常尿液中发现至少两组不同的抑制剂。第一组抑制剂的分子量高于10,000道尔顿,而第二组抑制剂的分子量在500 - 1,000道尔顿范围内。经过500道尔顿过滤后,D.I.值的平均值从正常范围(小于0.6)急剧增加到结石形成者范围(大于1.1)(p小于0.001)。一些正常尿液即使经过500道尔顿过滤后仍具有一定程度的抑制潜力。这种抑制潜力可能与尿液中发现的无机化合物有关。在7份结石形成者(SF)尿液中,分子量高于10,000道尔顿和低于500道尔顿的大分子的抑制活性可忽略不计。500 - 1,000道尔顿大分子在SF尿液和正常尿液中的相对贡献最高。
1)人尿中的抑制剂分子量范围广泛;2)结石形成者和正常人在所有分子量范围内的抑制剂活性水平不同;尤其是分子量高于10,000道尔顿和低于该值的抑制剂。